190 related articles for article (PubMed ID: 22086304)
1. Hereditary leiomyomatosis and renal cell cancer presenting as metastatic kidney cancer at 18 years of age: implications for surveillance.
van Spaendonck-Zwarts KY; Badeloe S; Oosting SF; Hovenga S; Semmelink HJ; van Moorselaar RJ; van Waesberghe JH; Mensenkamp AR; Menko FH
Fam Cancer; 2012 Mar; 11(1):123-9. PubMed ID: 22086304
[TBL] [Abstract][Full Text] [Related]
2. Radical nephrectomy and regional lymph node dissection for locally advanced type 2 papillary renal cell carcinoma in an at-risk individual from a family with hereditary leiomyomatosis and renal cell cancer: a case report.
Kamai T; Abe H; Arai K; Murakami S; Sakamoto S; Kaji Y; Yoshida KI
BMC Cancer; 2016 Mar; 16():232. PubMed ID: 26983443
[TBL] [Abstract][Full Text] [Related]
3. Renal cell carcinoma in young FH mutation carriers: case series and review of the literature.
Hol JA; Jongmans MCJ; Littooij AS; de Krijger RR; Kuiper RP; van Harssel JJT; Mensenkamp A; Simons M; Tytgat GAM; van den Heuvel-Eibrink MM; van Grotel M
Fam Cancer; 2020 Jan; 19(1):55-63. PubMed ID: 31792767
[TBL] [Abstract][Full Text] [Related]
4. Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis.
Smit DL; Mensenkamp AR; Badeloe S; Breuning MH; Simon ME; van Spaendonck KY; Aalfs CM; Post JG; Shanley S; Krapels IP; Hoefsloot LH; van Moorselaar RJ; Starink TM; Bayley JP; Frank J; van Steensel MA; Menko FH
Clin Genet; 2011 Jan; 79(1):49-59. PubMed ID: 20618355
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America.
Toro JR; Nickerson ML; Wei MH; Warren MB; Glenn GM; Turner ML; Stewart L; Duray P; Tourre O; Sharma N; Choyke P; Stratton P; Merino M; Walther MM; Linehan WM; Schmidt LS; Zbar B
Am J Hum Genet; 2003 Jul; 73(1):95-106. PubMed ID: 12772087
[TBL] [Abstract][Full Text] [Related]
6. The syndrome of hereditary leiomyomatosis and renal cell cancer (HLRCC): The clinical features of an individual with a fumarate hydratase gene mutation.
Varol A; Stapleton K; Roscioli T
Australas J Dermatol; 2006 Nov; 47(4):274-6. PubMed ID: 17034471
[TBL] [Abstract][Full Text] [Related]
7. Familial renal cancer as an indicator of hereditary leiomyomatosis and renal cell cancer syndrome.
Raymond VM; Herron CM; Giordano TJ; Gruber SB
Fam Cancer; 2012 Mar; 11(1):115-21. PubMed ID: 22127509
[TBL] [Abstract][Full Text] [Related]
8. Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry.
Chen YB; Brannon AR; Toubaji A; Dudas ME; Won HH; Al-Ahmadie HA; Fine SW; Gopalan A; Frizzell N; Voss MH; Russo P; Berger MF; Tickoo SK; Reuter VE
Am J Surg Pathol; 2014 May; 38(5):627-37. PubMed ID: 24441663
[TBL] [Abstract][Full Text] [Related]
9. Review of hereditary leiomyomatosis renal cell carcinoma with focus on clinical and pathobiological aspects of renal tumors.
Kuroda N; Ohe C; Kato I; Furuya M; Baba M; Nagashima Y; Nakatani Y; Murakami I; Zhou M; Michal M; He O; Amin MB
Pol J Pathol; 2017; 68(4):284-290. PubMed ID: 29517197
[TBL] [Abstract][Full Text] [Related]
10. Hereditary leiomyomatosis and renal cell cancer syndrome: a family affair.
Teh J; Kinnear N; Douglass-Molloy H; Hennessey DB
BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28122802
[TBL] [Abstract][Full Text] [Related]
11. Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome.
Sanz-Ortega J; Vocke C; Stratton P; Linehan WM; Merino MJ
Am J Surg Pathol; 2013 Jan; 37(1):74-80. PubMed ID: 23211287
[TBL] [Abstract][Full Text] [Related]
12. Fumarate Hydratase Mutation in a Young Woman With Uterine Leiomyomas and a Family History of Renal Cell Cancer.
Mann ML; Ezzati M; Tarnawa ED; Carr BR
Obstet Gynecol; 2015 Jul; 126(1):90-2. PubMed ID: 25923021
[TBL] [Abstract][Full Text] [Related]
13. Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC): Report of a Family Pedigree.
Choi G; Kimonis V; Hall K; Lau WL
Am J Med Sci; 2020 Dec; 360(6):724-727. PubMed ID: 32703534
[TBL] [Abstract][Full Text] [Related]
14. Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma.
Gardie B; Remenieras A; Kattygnarath D; Bombled J; Lefèvre S; Perrier-Trudova V; Rustin P; Barrois M; Slama A; Avril MF; Bessis D; Caron O; Caux F; Collignon P; Coupier I; Cremin C; Dollfus H; Dugast C; Escudier B; Faivre L; Field M; Gilbert-Dussardier B; Janin N; Leport Y; Leroux D; Lipsker D; Malthieu F; McGilliwray B; Maugard C; Méjean A; Mortemousque I; Plessis G; Poppe B; Pruvost-Balland C; Rooker S; Roume J; Soufir N; Steinraths M; Tan MH; Théodore C; Thomas L; Vabres P; Van Glabeke E; Meric JB; Verkarre V; Lenoir G; Joulin V; Deveaux S; Cusin V; Feunteun J; Teh BT; Bressac-de Paillerets B; Richard S;
J Med Genet; 2011 Apr; 48(4):226-34. PubMed ID: 21398687
[TBL] [Abstract][Full Text] [Related]
15. Association of germline mutations in the fumarate hydratase gene and uterine fibroids in women with hereditary leiomyomatosis and renal cell cancer.
Stewart L; Glenn GM; Stratton P; Goldstein AM; Merino MJ; Tucker MA; Linehan WM; Toro JR
Arch Dermatol; 2008 Dec; 144(12):1584-92. PubMed ID: 19075141
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and treatments of hereditary leiomyomatosis renal cell carcinoma: two case reports and literature review.
Feng D; Wang M; Zhang X; Wang J
Aktuelle Urol; 2021 Feb; 52(1):58-63. PubMed ID: 32932527
[TBL] [Abstract][Full Text] [Related]
17. Morphologic features of uterine leiomyomas associated with hereditary leiomyomatosis and renal cell carcinoma syndrome: a case report.
Garg K; Tickoo SK; Soslow RA; Reuter VE
Am J Surg Pathol; 2011 Aug; 35(8):1235-7. PubMed ID: 21753700
[TBL] [Abstract][Full Text] [Related]
18. [Hereditary leiomyomatosis and renal cell cancer - HLRCC/multiple cutaneous and uterine leimomyomatosis - MCUL].
Plevová P; Hladíková A; Tesařová M
Klin Onkol; 2012; 25 Suppl():S55-8. PubMed ID: 22920208
[TBL] [Abstract][Full Text] [Related]
19. Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment.
Menko FH; Maher ER; Schmidt LS; Middelton LA; Aittomäki K; Tomlinson I; Richard S; Linehan WM
Fam Cancer; 2014 Dec; 13(4):637-44. PubMed ID: 25012257
[TBL] [Abstract][Full Text] [Related]
20. Pattern multiplicity and fumarate hydratase (FH)/S-(2-succino)-cysteine (2SC) staining but not eosinophilic nucleoli with perinucleolar halos differentiate hereditary leiomyomatosis and renal cell carcinoma-associated renal cell carcinomas from kidney tumors without FH gene alteration.
Muller M; Guillaud-Bataille M; Salleron J; Genestie C; Deveaux S; Slama A; de Paillerets BB; Richard S; Benusiglio PR; Ferlicot S
Mod Pathol; 2018 Jun; 31(6):974-983. PubMed ID: 29410489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]